METABOLIC RISK FACTORS OF URINARY STONE DISEASE IN CHILDREN
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: To evaluate metabolic risk factor of urinary stone disease in children. Material & method: In this hospital-based preliminary study, children with urinary stone disease who underwent stone removal in Hasan Sadikin Hospital were included. Control group consisted children with other diseases, matched for age and BMI. Blood evaluation (uric acid, calcium and phosphate) and 24-hour urine evaluation (calcium, phosphate, sodium, magnesium, uric acid, acidity, and urine volume) were measured before the stone removal. Stone analysis was performed later. Data was analyzed using Kruskal Wallis and Spearman correlation test. Results: Eight subjects with urinary tract stone and 8 normal subjects were included to the study. This study included 4 (50%) subjects with renal stone, 3 (37,5%) subjects with bladder stone, and 1 (12,5%) subject with distal urethral stone. Stone analysis revealed 6 (75%) calcium oxalate, 1 (12,5%) calcium phosphate, and 1 (12,5%) struvite stone. There was no significant difference in blood calcium, phosphate, and uric acid between groups. 24 hours urinary calcium level was higher in subjects with stone disease (40,8 mg vs 10,6 mg, p=0,027). Urinary calcium-to-creatinine ratio was also higher in stone disease (0,23 vs 0,02 mg/mg creatinine, p=0,002). There was no significant difference of other urinary electrolites and uric acid level between groups. Conclusion: Twenty four hours urinary calcium level and urinary calcium-to-creatinine ratio is higher in children with urinary stone disease. Keywords: Urinary stone disease, children, metabolic risk factors.
##plugins.themes.bootstrap3.article.details##
Pearly MS, Lotan Y, Wein AJ. Urinary lithiasis: Etiology, epidemiology, and pathogenesis. In: Kavoussi LR, Novick AC, Partin AW, Peters CA (ed). Campbell-Walsh Urology. Saunders. 2007; 42.
Ho KV, Segura JW. Lower urinary tract calculi. In: Kavoussi LR, Novick AC, Partin AW, Peters CA (ed). Campbell-Walsh Urology. Saunders. 2007; 84.
Mishra K, Desai A, Patel S, Mankad M, Dave K. Role of percutaneous nephrostomy in advanced cervical carcinoma with obstructive uropathy: A case series. Indian J Palliat Care [serial online] 2009 [cited 2010 May 14]; 15: 37-40. Available from: http://www.jpalliativecare.com/ text.asp? 2009/15/1/37/53510
Battino BS, DeFoor W, Coe F, Tackett L, Erhard M, Wacksman J, et al. Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate? J Urol. 2002; 168, 2568-71.
Borawski KM, Sur RL, Miller OF, Pak CY, Preminger GM, Kolon TF. Urinary referene values for stone risk factors in children. J Urol. 2008; 179, 290-4.
Aggour A, Ziada AM, Hamid AZ, Abdelrahman S, Morsi A. Metabolic stone composition in egyptian children. Journal of Pediatric Urology. 2009; 5: 132-5.
DeFoor W, Asplin J, Jackson E, Jackson C, Reddy P, Sheldon C, et al. Urinary metabolic evaluation in normal and stone forming children. J Urol. 2006; 176: 1793-6.
Spivacow FR, Negri AL, del Valle EE, Calvino I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol. 2008; 23; 1129-33.
Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol. 2009; 24(11): 2203-9.
Bak M, Ural R, Agin H, Serdaroglu E, Calkavur S. The metabolic etiology of urolithiasis in Turkish children. Int Urol Nephrol. 2009; 41(3): 453-60.
Bartosh SM. Medical management of pediatric stone disease. Urol Clin North Am. 2004; 31(3): 575-87.
Ece A, Ozdemir E, Gurkan F, Dokucu AI, Akdeniz O. Characteristics of pediatric urolithiasis in south-east Anatolia. Int J Urol. 2000; 7(9): 330-4.
Erbagci A, Erbagci AB, Yilmaz M, Yagci F, Tarakcioglu M, Yurtseven C, et al. Pediatric urolithiasis-evaluation of risk factors in 95 children. Scand J Urol Nephrol. 2003; 37(2): 129-33.
Karabacak OR, Ipek B, Ozturk U, Demirel F, Saltas H, Altug U. Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease. Urology. 2007; 82(3): 20-34.
Khoory BJ, Pedrolli A, Vecchini S, Benini D, Fanos V. Renal calculosis in pediatrics. Pediatr Med Chir. 1998; 20(6): 367-76.
Ogawa Y, Yonou H, Hokama S, Oda M, Morozumi M, Sugaya K. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens. Front Biosci. 2003; 8(2): 167-76.
Sarica K. Pediatric urolithiasis: Etiology, specific pathogenesis and medical treatment. Urol Res. 2006; 34(2): 96-101.
Tabel Y, Akin IM, Tekin S. Clinical and demographic characteristics of children with urolithiasis: Single-center experience from eastern Turkey. Urol Int. 2009; 83(2): 217-21.
Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, et al. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int. 2003; 70(4): 273-7.
Alaya A, Abdellatif N, Najjar MF. Pediatric urolithiasis in coastal Tunisia. Urol Annal. 2009; 1(2): 39-43.
Rizvi A, Sultan S, Zafar MN, Ahmed B, Faiq SM, Hossain KZ, et al. Evaluation of children with urolithiasis. Indian Journal of Urology. 2007; 23(4): 420-7.
Sepahi MA, Heidari A, Shajari A. Clinical manifestations and etiology of renal stones in children less than 14 years age. Saudi Journal of Kidney Diseases and Transplantation. 2010; 21(1): 181-4.
Al-Rasheed S, Jurayyan NA, Nasser AN, Al-Mugeiren MM, Al-Salloum AA, Peterson BA. Nephrolithiasis in children and adolescents in the South Western Region of Saudi Arabia. Saudi Journal of Kidney Diseases and Transplantation. 1995; 6(4): 396-9.